Diurnal IOP curves have limited value in patients with POAG

Article

Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a newly published study.

Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a study newly published in Ophthalmology. A single curve poorly characterizes fluctuations in IOP, and patterns cannot be reproduced from month to month, researchers say.

French researchers conducted a database study of 92 patients who had POAG. The patients had their diurnal IOP curve measurements taken 4 times, 6 months apart. Goldmann applanation tonometry had been recorded with patients in the sitting position at 9 am, 10 am, 11 am, noon, 2 pm, 3 pm, 4 pm and 5 pm. Intraclass correlation coefficients (ICCs) were used to measure intervisit agreement of IOP by time point and of diurnal IOP curve parameters, including mean, standard deviation, range, maximum, maximum hour, minimum and minimum hour.

The researchers found generally poor agreement of between-visit agreement of IOP values at each time point. ICCs were 0.26 to 0.77 in all patients. Also, using the first diurnal IOP curve to predict the risk of IOP fluctuations during the 3 subsequent curves was of limited value. "Only 6.4% of the patients with an IOP range ≥30% of the mean IOP on the first curve presented similar fluctuations on the 3 subsequent curves; 77.1% of the patients who did not have an IOP range ≥30% of the mean IOP on the first curve had an IOP range ≥30% of the mean IOP on at least 1 of the 3 subsequent curves," they wrote.

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.